Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer

ClinicalTrials.gov ID: NCT00835978

Public ClinicalTrials.gov record NCT00835978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 6:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-blind Phase 2 Study Of Axitinib (Ag-013736) With Or Without Dose Titration In Patients With Metastatic Renal Cell Carcinoma

Study identification

NCT ID
NCT00835978
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
213 participants

Conditions and interventions

Interventions

  • axitinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2009
Primary completion
Sep 30, 2012
Completion
Jan 31, 2016
Last update posted
May 29, 2017

2009 – 2016

United States locations

U.S. sites
31
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
East Bay Medical Oncology/Hematology Medical Associates Inc. Antioch California 94531
Comprehensive Blood and Cancer Center Bakersfield California 93309
Bay Area Cancer Research Group, LLC Pleasant Hill California 94523
Diablo Valley Oncology and Hematology Medical Group Inc Pleasant Hill California 94523
East Bay Medical Oncology/Hematology Medical Associates Inc Pleasant Hill California 94523
East Bay Medical Oncology/Hematology Medical Associates Inc San Leandro California 94578
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202
Investigational Drug Services, IUHSCC Indianapolis Indiana 46202
IU Health University Hospital Indianapolis Indiana 46202
University of Maryland Greenebaum Cancer Center Baltimore Maryland 21201
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231
Johns Hopkins Hospital Baltimore Maryland 21287
Massachusetts General Hospital Boston Massachusetts 02114
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Cancer and Hematology Centers of Western Michigan Grand Rapids Michigan 49503
Barnes-Jewish Hospital St Louis Missouri 63110-1094
Washington University St Louis Missouri 63110
Nebraska Methodist Hospital Omaha Nebraska 68114
University of Nebraska Medical Center Omaha Nebraska 68198-7680
Nevada Cancer Institute Las Vegas Nevada 89135
The University Hospital Cincinnati Ohio 45219
University of Cincinnati Cincinnati Ohio 45219
Cleveland Clinic Cleveland Ohio 44195
The Ohio State University, James Cancer Hospital Columbus Ohio 43210
JamesCare in Kenny Columbus Ohio 43221
West Chester Hospital Medical Building West Chester Ohio 45069
Oregon Health and Science University Portland Oregon 97239
Texas Oncology, Sammons Cancer Center Dallas Texas 75246
The University of Texas MD Anderson Cancer Center Houston Texas 77030-4004
Virginia Mason Medical Center Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00835978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2017 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00835978 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →